Focus: Iambic Therapeutics is an AI-driven drug discovery biotech founded in 2023, focused on oncology, neurology, and gastroenterology indications. The company leverages artificial intelligence to accelerate early-stage therapeutic development.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Stable — net -1 jobs in 30d
5 added, 6 removed. Backfill posture.
A high-risk, high-upside early-stage platform play best suited for scientists and engineers comfortable with startup volatility in exchange for meaningful equity and technology ownership.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Iambic Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Iambic Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Price to sales forward of Iambic Therapeutics Inc. – NASDAQ:IAM - TradingView
Price to sales forward of Iambic Therapeutics Inc. – NASDAQ:IAM TradingView
Iambic Therapeutics Inc. Cash Flow – NASDAQ:IAM - TradingView
Iambic Therapeutics Inc. Cash Flow – NASDAQ:IAM TradingView
Iambic Therapeutics Inc. Revenue Breakdown – NASDAQ:IAM - TradingView
Iambic Therapeutics Inc. Revenue Breakdown – NASDAQ:IAM TradingView
Non-controlling/minority interest of Iambic Therapeutics Inc. – NASDAQ:IAM - TradingView
Non-controlling/minority interest of Iambic Therapeutics Inc. – NASDAQ:IAM TradingView
After tax other income/expense of Iambic Therapeutics Inc. – NASDAQ:IAM - TradingView
After tax other income/expense of Iambic Therapeutics Inc. – NASDAQ:IAM TradingView
Iambic Therapeutics Inc. Balance Sheet – NASDAQ:IAM - TradingView
Iambic Therapeutics Inc. Balance Sheet – NASDAQ:IAM TradingView
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 7 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo